Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All ivermectin studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19ivm.org COVID-19 treatment researchIvermectinIvermectin (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Identification of inositol monophosphatase as a broad‐spectrum antiviral target of ivermectin

Jitobaom et al., Journal of Medical Virology, doi:10.1002/jmv.29552
Mar 2024  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Ivermectin for COVID-19
4th treatment shown to reduce risk in August 2020
 
*, now known with p < 0.00000000001 from 102 studies, recognized in 22 countries.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,000+ studies for 60+ treatments. c19ivm.org
In vitro study showing that ivermectin inhibits dengue, Zika, and SARS-CoV-2 by targeting the host protein inositol monophosphatase (IMPase). Authors used thermal proteomic profiling to identify IMPase as a target of ivermectin in human cells. Ivermectin inhibited IMPase activity, reduced cellular myo-inositol and phosphatidylinositol-4-phosphate levels, and this inhibition could be partially reversed with inositol. The results suggest that inhibition of IMPase leading to depletion of cellular myo-inositol and phosphatidylinositol-4-phosphate may be an important antiviral mechanism of ivermectin against various RNA viruses that depend on these molecules for replication organelle formation. Results focus on dengue and Zika, perhaps due to issues related to publishing positive results for SARS-CoV-2, however Figure 6 shows 2µm ivermectin inhibiting SARS-CoV-2.
Ivermectin, better known for antiparasitic activity, is a broad spectrum antiviral with activity against many viruses including H7N7 Götz, Dengue Jitobaom, Tay, Wagstaff, HIV-1 Wagstaff, Simian virus 40 Wagstaff (B), Zika Barrows, Jitobaom, Yang, West Nile Yang, Yellow Fever Mastrangelo, Varghese, Japanese encephalitis Mastrangelo, Chikungunya Varghese, Semliki Forest virus Varghese, Human papillomavirus Li, Epstein-Barr Li, BK Polyomavirus Bennett, and Sindbis virus Varghese.
Ivermectin inhibits importin-α/β-dependent nuclear import of viral proteins Götz, Kosyna, Wagstaff, Wagstaff (B), inhibits SARS-CoV-2 3CLpro Mody, shows spike-ACE2 disruption at 1nM with microfluidic diffusional sizing Fauquet, binds to glycan sites on the SARS-CoV-2 spike protein preventing interaction with blood and epithelial cells and inhibiting hemagglutination Boschi, Scheim, exhibits dose-dependent inhibition of lung injury Abd-Elmawla, Ma, may inhibit SARS-CoV-2 via IMPase inhibition Jitobaom, may inhibit SARS-CoV-2 induced formation of fibrin clots resistant to degradation Vottero, may inhibit SARS-CoV-2 RdRp activity Parvez (B), may be beneficial for COVID-19 ARDS by blocking GSDMD and NET formation Liu (C), shows protection against inflammation, cytokine storm, and mortality in an LPS mouse model sharing key pathological features of severe COVID-19 DiNicolantonio, Zhang, may be beneficial in severe COVID-19 by binding IGF1 to inhibit the promotion of inflammation, fibrosis, and cell proliferation that leads to lung damage Zhao, may minimize SARS-CoV-2 induced cardiac damage Liu, Liu (B), increases Bifidobacteria which play a key role in the immune system Hazan, has immunomodulatory Munson and anti-inflammatory DiNicolantonio (B), Yan properties, and has an extensive and very positive safety profile Descotes.
Jitobaom et al., 21 Mar 2024, peer-reviewed, 9 authors. Contact: prasert.aue@mahidol.ac.th.
In Vitro studies are an important part of preclinical research, however results may be very different in vivo.
This PaperIvermectinAll
Identification of inositol monophosphatase as a broad‐spectrum antiviral target of ivermectin
Kunlakanya Jitobaom, Paleerath Peerapen, Usa Boonyuen, Ittipat Meewan, Chompunuch Boonarkart, Thanyaporn Sirihongthong, Songkran Thongon, Visith Thongboonkerd, Prasert Auewarakul
Journal of Medical Virology, doi:10.1002/jmv.29552
Ivermectin has broad-spectrum antiviral activities. Despite the failure in clinical application of COVID-19, it can serve as a lead compound for the development of more effective broad-spectrum antivirals, for which a better understanding of its antiviral mechanisms is essential. We thus searched for potential novel targets of ivermectin in host cells by label-free thermal proteomic profiling using Huh-7 cells. Inositol monophosphatase (IMPase) was found among the proteins with shifted thermal stability by ivermectin. Ivermectin could inhibit IMPase activity and reduce cellular myo-inositol and phosphatidylinositol-4-phosphate levels. On the other hand, inositol could impair the antiviral activity of ivermectin and lithium, an IMPase inhibitor with known antiviral activity. As phosphatidylinositol phosphate is crucial for the replication of many RNA viruses, inhibition of cellular myo-inositol biosynthesis may be an important antiviral mechanism of ivermectin. Hence, inhibition of IMPase could serve as a potential target for broad-spectrum antiviral development.
AUTHOR CONTRIBUTIONS Kunlakanya CONFLICT OF INTEREST STATEMENT The authors declare no conflict of interest. SUPPORTING INFORMATION Additional supporting information can be found online in the Supporting Information section at the end of this article. How to cite this article: Jitobaom K, Peerapen P, Boonyuen
References
Altan-Bonnet, Balla, Phosphatidylinositol 4-kinases: hostages harnessed to build panviral replication platforms, Trends Biochem Sci
Amsterdam, Maislin, Rybakowski, A possible antiviral action of lithium carbonate in herpes simplex virus infections, Biol Psychiatry
Barrows, Campos, Powell, A screen of FDA-approved drugs for inhibitors of Zika virus infection, Cell Host Microbe
Chatel-Chaix, Bartenschlager, Dengue virus-and hepatitis C virus-induced replication and assembly compartments: the enemy inside-caught in the web, J Virol
Ci, Yang, Xu, Qin, Shi, Electrostatic interaction between NS1 and negatively charged lipids contributes to flavivirus replication organelles formation, Front Microbiol
Cui, Xie, Gao, Inhibitory effects of LiCl on replication of type II porcine reproductive and respiratory syndrome virus in vitro, Antivir Ther
Delang, Paeshuyse, Neyts, The role of phosphatidylinositol 4-kinases and phosphatidylinositol 4-phosphate during viral replication, Biochem Pharmacol
Fauroux, Freeman, Inhibitors of inositol monophosphatase, J Enzym Inhib
Fischl, Bartenschlager, Exploitation of cellular pathways by dengue virus, Curr Opin Microbiol
Franken, Mathieson, Childs, Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry, Nat Protoc
Gholizadeh, Karbalaei, Khaleghian, Identification of Celecoxib targeted proteins using label-free thermal proteome profiling on rat hippocampus, Mol Pharmacol
Götz, Magar, Dornfeld, Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import, Sci Rep
Harrison, Tarpey, Rothwell, Kaiser, Hiscox, Lithium chloride inhibits the coronavirus infectious bronchitis virus in cell culture, Avian Pathol
Hsu, Ilnytska, Belov, Viral reorganization of the secretory pathway generates distinct organelles for RNA replication, Cell
Jani, Makai, Kis, Ivermectin interacts with human ABCG2, J Pharm Sci
Jin, Du, Xu, Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors, Nature
Jin, Feng, Rong, The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism, Nat Commun
Jitobaom, Boonarkart, Manopwisedjaroen, Synergistic anti-SARS-CoV-2 activity of repurposed anti-parasitic drug combinations, BMC Pharmacol Toxicol
Karlgren, Ahlin, Bergström, Svensson, Palm et al., In vitro and in silico strategies to identify OATP1B1 inhibitors and predict clinical drug-drug interactions, Pharm Res
Lehrer, Rheinstein, Ivermectin docks to the SARS-CoV-2 spike receptor-binding domain attached to ACE2, Vivo
Lespine, Dupuy, Orlowski, Interaction of ivermectin with multidrug resistance proteins (MRP1, 2 and 3), Chem Biol Interact
Li, Wang, Cheng, Enterovirus replication organelles and inhibitors of their formation, Front Microbiol
Liu, Fang, Sun, Liu, Anthelmintic drug ivermectin inhibits angiogenesis, growth and survival of glioblastoma through inducing mitochondrial dysfunction and oxidative stress, Biochem Biophys Res Commun
Liu, Grimm, Dai, Hou, Xiao et al., CB-Dock: a web server for cavity detection-guided protein-ligand blind docking, Acta Pharmacol Sin
Liu, Zhang, Cheng, Zhu, Xu, Progress in understanding the molecular mechanisms underlying the antitumour effects of ivermectin, Drug Des Devel Ther
Martin, Robertson, Choudhary, Ivermectin: an anthelmintic, an insecticide, and much more, Trends Parasitol
Mazeaud, Pahmeier, The biogenesis of dengue virus replication organelles requires the ATPase activity of valosincontaining protein, Viruses
Mcknight, Adida, Budge, Stockton, Goodwin et al., Lithium toxicity profile: a systematic review and metaanalysis, Lancet
Mcphail, Burke, Drugging the phosphoinositide 3-Kinase (PI3K) and phosphatidylinositol 4-kinase (PI4K) family of enzymes for treatment of cancer, immune disorders, and viral/parasitic infections, Adv Exp Med Biol
Mcphail, Burke, Molecular mechanisms of PI4K regulation and their involvement in viral replication, Traffic
Ohnishi, Ohba, Seo, Spatial expression patterns and biochemical properties distinguish a second myo-inositol monophosphatase IMPA2 from IMPA1, J Biol Chem
Pedley, Benkovic, A new view into the regulation of purine metabolism: the purinosome, Trends Biochem Sci
Posor, Jang, Haucke, Phosphoinositides as membrane organizers, Nat Rev Mol Cell Biol
Pouliot, Heureux, Liu, Prichard, Reversal of P-glycoprotein-associated multidrug resistance by ivermectin, Biochem Pharmacol
Puertas, Salgado, Morón-López, Effect of lithium on HIV-1 expression and proviral reservoir size in the CD4+ T cells of antiretroviral therapy suppressed patients, AIDS
Qaswal, Suleiman, Guzu, Harb, Atiyat, The potential role of lithium as an antiviral agent against SARS-CoV-2 via membrane depolarization: review and hypothesis, Sci Pharm
Quiroz, Molecular effects of lithium, Mol Interv
Richards, Soares-Martins, Riddell, Jackson, Generation of unique poliovirus RNA replication organelles, mBio
Rim, Atta, Dahl, Berry, Handler et al., Transcription of the sodium/myo-inositol cotransporter gene is regulated by multiple tonicity-responsive enhancers spread over 50 kilobase pairs in the 5′-flanking region, J Biol Chem
Schneider, Inositol transport proteins, FEBS Lett
Shaw Research, Schrödinger release 2020-1: desmond molecular dynamics system
Suputtamongkol, Avirutnan, Mairiang, Ivermectin accelerates circulating nonstructural protein 1 (NS1) clearance in adult dengue patients: a combined phase 2/3 randomized doubleblinded placebo controlled trial, Clin Infect Dis
Tay, Fraser, Chan, Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor ivermectin, Antiviral Res
Thaker, Ch'ng, Hr, Viral hijacking of cellular metabolism, BMC Biol
Trott, Olson, AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading, J Comput Chem
Ullah, Li, Fang, Xiao, Fang, DEAD/H-box helicases: anti-viral and pro-viral roles during infections, Virus Res
Wagstaff, Sivakumaran, Heaton, Harrich, Jans, Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus, Biochem J
Wang, Xu, Wan, Hu, Antibiotic ivermectin selectively induces apoptosis in chronic myeloid leukemia through inducing mitochondrial dysfunction and oxidative stress, Biochem Biophys Res Commun
Yang, Atkinson, Wang, The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer, Antiviral Res
Yang, Ma, Lang, Phosphatidylinositol 4-kinase IIIβ is required for severe acute respiratory syndrome coronavirus spikemediated cell entry, J Biol Chem
Zaidi, Dehgani-Mobaraki, The mechanisms of action of ivermectin against SARS-CoV-2-an extensive review, J Antibiot
Zeng, Andrew, Woda, Halley, Crouch et al., Role of cytochrome P450 isoforms in the metabolism of abamectin and ivermectin in rats, J Agricult Food Chem
Zhang, Wang, Zhang, RNA-binding protein YTHDF3 suppresses interferon-dependent antiviral responses by promoting FOXO3 translation, Proc Natl Acad Sci
Zhao, Yan, Wang, Lithium chloride confers protection against viral myocarditis via suppression of coxsackievirus B3 virus replication, Microb Pathog
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit